Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference.
Parexel
Unlock to Claim this listing
Add / Modify Company
2.04
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Pharmaceutical ManufacturingESG/Ethical Impact
Parexel exemplifies a strong environmental commitment through various initiatives aimed at minimizing its ecological footprint. The company emphasizes sustainable practices by implementing energy-efficient technologies, optimizing its resource utilization, and reducing waste generation across its operations. The company plays a pivotal role in advancing medical research and drug development, ultimately leading to better patient care and treatment options. Additionally, Parexel engages in community outreach, educational initiatives, and partnerships that promote health awareness and access to medical advancements. By collaborating with patient advocacy groups and healthcare professionals, Parexel contributes to societal well-being by driving innovation, promoting medical education, and enhancing patient outcomes. Parexel maintains a strong governance structure that upholds ethical standards and transparency across its operations. The company’s leadership ensures rigorous compliance with regulatory requirements, adheres to ethical research practices, and fosters a culture of integrity and accountability. Parexel’s commitment to governance extends to its interactions with stakeholders, including clients, employees, and investors, fostering trust and responsible decision-making. Through these ethical practices, Parexel exemplifies industry leadership in promoting ethical conduct, regulatory compliance, and robust governance principles. Aligned with its ESG values, Parexel recognizes the inherent link between responsible practices and long-term financial performance. The company’s integration of sustainability considerations into its financial strategy fosters sustainable growth and resilience. By effectively managing risks, optimizing operational efficiency, and aligning its financial goals with ESG principles, Parexel creates value for both shareholders and the healthcare ecosystem. Ethics are at the core of Parexel’s operations, ensuring patient safety, data integrity, and ethical research practices. The company’s commitment to high ethical standards encompasses its collaborations with pharmaceutical partners, clinical trial conduct, and interactions with patients. Parexel’s dedication to upholding scientific rigor, ensuring data accuracy, and adhering to ethical guidelines sets a benchmark for ethical excellence within the industry. By prioritizing ethical conduct, Parexel instills confidence in patients, regulators, and stakeholders, ultimately advancing healthcare through responsible research and development practices.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
3800000000.00
Website Traffic
Employee Rating
4.10
Customer Rating
4.00
Company Size
10000+
ESG Risk Rating
3.00